Feature Channels:

Biotech

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Science

Channels:

Nanoparticles, Material Science, Biosensors, Biomedical, Nanoengineering, Biotechnology

Brightest Fluorescent Nanoparticles Synthesized

tem-nanoparticles.jpg

Clarkson University Physics Professor Igor Sokolov and his team have discovered a method of making the brightest ever synthesized fluorescent silica nanoparticles.

Science

Channels:

Liquid Lens, Mechanical Engineering, Darpa, Drug Delivery, Microfluidics, Opthamology, Biotechnology

“Liquid Pistons” Could Drive New Advances in Camera Lenses and Drug Delivery

RPILiquidPistons1_1.jpg

A few unassuming drops of liquid locked in a very precise game of “follow the leader” could one day be found in mobile phone cameras, medical imaging equipment, implantable drug delivery devices, and even implantable eye lenses. DARPA-funded study published in the peer-reviewed journal, Lab on a Chip.

Science

Channels:

Study Identifies Cells that Give Rise to Brown Fat

Yu-Hua_Tseng_PhD.jpg

In a step toward novel weight-loss therapies, Joslin Diabetes Center scientists identify cells in mice that can be triggered to transform into energy-burning brown fat.

Science

Channels:

Genetics, Biotechnology, Environmental, Energy fuels (non petroleum), Fossil Fuels

"Green Genes" in Yeast May Boost Biofuel Production

An effort to increase biofuel production has led scientists to discover genes in yeast that improve their tolerance to ethanol, allowing the production of more ethanol from the same amount of nutrients. This study shows how genetically altered yeast cells survive higher ethanol concentrations, addressing a bottleneck in the production of ethanol from cellulosic material (nonfood plant sources) in quantities that could compete economically with fossil fuels.

Science

Channels:

Neuroscience, Spinal Cord Injury, Robotics, brain-computer interface, Biotechnology

Robot Arm Improves Performance of Brain-Controlled Device

The performance of a brain-machine interface designed to help paralyzed subjects move objects with their thoughts is improved with the addition of a robotic arm providing sensory feedback, a new study from the University of Chicago finds.

Medicine

Channels:

Rensselaer Polytechnic Institute, Center for Biotechnology and Interdisciplinary Studies at Rensselaer, Biotechnology, Medicine, Alzheimer's Disease, Parkinson's Disease, blood-brain barrier

Delivering Drugs to the Brain: New Research into Targeted Treatment of Alzheimer’s and Other Brain Illnesses

Pankaj Karande, a Rensselaer Polytechnic Institute assistant professor of chemical and biological engineering, is among a new generation of scientists and engineers developing exciting and novel new techniques to treat some of the most complex brain illnesses, including Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and brain cancer. His research has already attracted the interest of the Goldhirsh Foundation and now has garnered the support of the Alzheimer’s Association with an additional $80,000 in research funding.

Science

Channels:

Orphan Diseases, Muscular Dystrophy, Duchenne Muscular Dystrophy, Tarantula Venom Peptide, Tarantulas, Clinical Trial, Orphan Drugs, GsMTx4, Biotechnology, Entrepreneurship

UB Wins Orphan Designation for Drug from Spider Venom

FrederickSachsAndRosie101.jpg

As Rose Pharmaceuticals marks its first anniversary this month, the stockbroker and University at Buffalo researchers who founded the company are celebrating a year of accomplishments.

Business

Channels:

UTHealth, BioHouston Sign Collaborative Agreement

ButlerNorthcut.jpg

The University of Texas Health Science Center at Houston (UTHealth) and BioHouston, Inc. on Oct. 21 announced a new agreement to boost services to biomedical entrepreneurs and new bio-tech start-ups in Houston.

Science

Channels:

Lifesciences Summit Brings "Bench-to-Bedside" Scientists With Bioscience Execs

The Center for Biotechnology at SBU has organized a summit that will bring some of the world’s top bioscience companies together with entrepreneurs and academic innovators to explore the next generation of biomedical solutions.

Medicine

Channels:

Novel Study Using Reoviruses Against Ovarian Cancer Pushes Forward

Calgary-based Oncolytics Biotech Inc. recently announced that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN® in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.







Chat now!